The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Uganda currently stands at 98%, indicating a decrease of 2% (-2.0%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Uganda
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Uganda
PMTCT antiretroviral therapy coverage
More indicators for Uganda
Male unintentional poisoning
2.2
0.0
(2019)
Female wasting in children
4.4%
+0.8%
(2020)
Female prevalence of HIV
2.5%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar37
+intl dollar2
(2021)
Birth registration
32.2%
-6.8%
(2016)
Contraceptive modern method prevalence
42.7%
+5.4%
(2021)
Uganda PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 98% | -2% |
| 2021 | 100% | 0% |
| 2020 | 100% | 0% |
| 2019 | 100% | 0% |
| 2018 | 100% | 0% |
| 2017 | 100% | 0% |
| 2016 | 100% | 0% |
| 2015 | 100% | 0% |
| 2014 | 100% | 0% |
| 2013 | 100% | +7% |
| 2012 | 93% | +34% |
| 2011 | 59% | +24% |
| 2010 | 35% | -24% |
| 2009 | 59% | +6% |
| 2008 | 53% | +19% |
| 2007 | 34% | +8% |
| 2006 | 26% | +8% |
| 2005 | 18% | +7% |
| 2004 | 11% | +6% |
| 2003 | 5% | +5% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |